SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

1672 (1672) News

Track canonical SquawkNews coverage tagged to 1672, 1672. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 1672 Asset market Sector Markets 90 days 1 Updated Aug 30, 2026, 10:15 AM UTC Open live news feed
L Ascletis says first participant dosed in Phase III for ASC30 Ascletis announced the first participant has been dosed in its global Phase III clinical program of once-daily oral small-molecule GLP-1 receptor agonist ASC30 for chronic weight management. EQUITY | Aug 30, 2026, 10:15 AM UTC